Neal Shore

Neal Shore, MD, FACS, is a GU oncologist and medical director of the Carolina Urologic Research Center, specializing in prostate cancer management. In this engaging discussion, he elaborates on the latest guidelines for androgen deprivation therapy (ADT) and emphasizes the critical nature of shared decision-making in treatment. Dr. Shore highlights the safety and quality of life impacts of ADT, including strategies to mitigate its adverse effects and the role of a multidisciplinary team in ensuring optimal care.